Furthermore, the haploid loss of TAK1 expression, another suppressor of RIPK1, in a myeloid lineage of TBK1+/− mice, leads to late-onset ALS/FTD-like pathology facilitated via diminished RIPK1 inhibition. Here, RIPK1 is linked to amyotrophic lateral sclerosis.